Kirin Holdings Company, Limited - 2503.T

2503.T Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
2503.T	-0.1	-2.8	-6.9	-13.0	-10.9	-8.1	5.5	-22.3	29.1	83.4
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare 2503.T with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	2503.T
name	Kirin Holdings Company, Limited
price	1915
changes percentage	-0.1043
change	-2
day low	1902
day high	1916.5
year high	2310
year low	1896
market cap	1550817569405
price avg 50	2077.05
price avg 200	2148.8525
exchange	JPX
volume	2705200
avg volume	2556006
open	1913
previous close	1917
eps	133.42
pe	14.35
earnings announcement	2025-02-14T06:30:00.000+0000
shares outstanding	809826407
timestamp	2025-01-17 06:45:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 84.3%

Overall Quarterly Financial Health: 76.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	2134393000000	1989468000000	7.28
gross profit	920792000000	905713000000	1.66
gross profit ratio	0.43	0.46	-5.24
research and development expenses	85181000000	81367000000	4.69
operating expenses	719583000000	789694000000	-8.88
interest income	3546000000	10978000000	-67.70
interest expense	6579000000	6478000000	1.56
ebitda	294799000000	260362000000	13.23
ebitdaratio	0.14	0.12	16.57
operating income	201209000000	116019000000	73.43
operating income ratio	0.09	0.06	61.65
net income	112697000000	111007000000	1.52
net income ratio	0.05	0.06	-5.37
eps	139.16	135.09	3.01

Overall Score of Annual Income Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 2,134,393 million in 2023 from 1,989,468 million in 2022 representing a change of 7.28%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 920,792 million in 2023 from 905,713 million in 2022 representing a change of 1.66%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 85,181 million in 2023 from 81,367 million in 2022 representing a change of 4.69%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 719,583 million in 2023 from 789,694 million in 2022 representing a change of -8.88%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 294,799 million in 2023 from 260,362 million in 2022 representing a change of 13.23%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 201,209 million in 2023 from 116,019 million in 2022 representing a change of 73.43%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 112,697 million in 2023 from 111,007 million in 2022 representing a change of 1.52%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 139.16 in 2023 from 139.16 in 2022 representing a change of 3.01%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	594061000000	501762000000	18.39
gross profit	272933000000	228749000000	19.32
gross profit ratio	0.46	0.46	0.78
research and development expenses	100000000	26165000000	-99.62
operating expenses	222873000000	195694000000	13.89
interest income	5052000000	6667000000	-24.22
interest expense	2028000000	2341000000	-13.37
ebitda	88624000000	58866000000	50.55
ebitdaratio	0.15	0.11	37.54
operating income	59913000000	33055000000	81.25
operating income ratio	0.1	0.07	53.09
net income	31320000000	25900000000	20.93
net income ratio	0.05	0.05	2.14
eps	38.67	31.98	20.92

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 594,061 million in 2024Q2 from 501,762 million in 2024Q1 representing a change of 18.39%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 272,933 million in 2024Q2 from 228,749 million in 2024Q1 representing a change of 19.32%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 88,624 million in 2024Q2 from 58,866 million in 2024Q1 representing a change of 50.55%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 59,913 million in 2024Q2 from 33,055 million in 2024Q1 representing a change of 81.25%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 31,320 million in 2024Q2 from 25,900 million in 2024Q1 representing a change of 20.93%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 38.67 in 2024Q2 from 38.67 in 2024Q1 representing a change of 20.92%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 100 million in 2024Q2 from 26,165 million in 2024Q1 representing a change of -99.62%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 222,873 million in 2024Q2 from 195,694 million in 2024Q1 representing a change of 13.89%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	2869585000000	2542263000000	12.88
total liabilities	1443747000000	1289060000000	12.00
total equity	1425838000000	1253203000000	13.78
cash and cash equivalents	131399000000	88060000000	49.22
short term investments	8944000000	8376000000	6.78
long term investments	476066000000	456768000000	4.22
total current assets	957821000000	887021000000	7.98
total non current assets	1911764000000	1655242000000	15.50
total current liabilities	672806000000	632695000000	6.34
total non current liabilities	770941000000	656365000000	17.46
common stock	102046000000	102046000000	0.00
retained earnings	1128541000000	1063823000000	6.08
total debt	733080000000	523121000000	40.14

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 2,869,585 million in 2023 from 2,542,263 million in 2022 representing a change of 12.88%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,425,838 million in 2023 from 1,253,203 million in 2022 representing a change of 13.78%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 131,399 million in 2023 from 88,060 million in 2022 representing a change of 49.22%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 8,944 million in 2023 from 8,376 million in 2022 representing a change of 6.78%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 957,821 million in 2023 from 887,021 million in 2022 representing a change of 7.98%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 1,128,541 million in 2023 from 1,063,823 million in 2022 representing a change of 6.08%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,443,747 million in 2023 from 1,289,060 million in 2022 representing a change of 12.0%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 672,806 million in 2023 from 632,695 million in 2022 representing a change of 6.34%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 733,080 million in 2023 from 523,121 million in 2022 representing a change of 40.14%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	3134909000000	3004699000000	4.33
total liabilities	1546611000000	1547240000000	-0.04
total equity	1588298000000	1457459000000	8.98
cash and cash equivalents	138406000000	151207000000	-8.47
short term investments	0	8938000000	-100.00
long term investments	492658000000	476646000000	3.36
total current assets	1017684000000	977905000000	4.07
total non current assets	2117225000000	2026794000000	4.46
total current liabilities	717449000000	693399000000	3.47
total non current liabilities	829162000000	853841000000	-2.89
common stock	102046000000	102046000000	0.00
retained earnings	1155634000000	1124528000000	2.77
total debt	727273000000	757469000000	-3.99

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 3,134,909 million in 2024Q2 from 3,004,699 million in 2024Q1 representing a change of 4.33%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 1,546,611 million in 2024Q2 from 1,547,240 million in 2024Q1 representing a change of -0.04%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 1,588,298 million in 2024Q2 from 1,457,459 million in 2024Q1 representing a change of 8.98%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 1,017,684 million in 2024Q2 from 977,905 million in 2024Q1 representing a change of 4.07%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 1,155,634 million in 2024Q2 from 1,124,528 million in 2024Q1 representing a change of 2.77%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 727,273 million in 2024Q2 from 757,469 million in 2024Q1 representing a change of -3.99%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 138,406 million in 2024Q2 from 151,207 million in 2024Q1 representing a change of -8.47%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024Q2 from 8,938 million in 2024Q1 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 717,449 million in 2024Q2 from 693,399 million in 2024Q1 representing a change of 3.47%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	43339000000	-61428000000	170.55
operating cash flow	203206000000	135562000000	49.90
free cash flow	89396000000	37083000000	141.07
capital expenditure	-113810000000	-98479000000	-15.57
depreciation and amortization	87227000000	85937000000	1.50
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	10972000000	18384000000	-40.32
inventory	-20063000000	-39490000000	49.19
acquisitions net	-151614000000	66684000000	-327.36
investments in property plant and equipment	-113810000000	-98479000000	-15.57
net cash used for investing activites	-226091000000	-10399000000	-2074.16
debt repayment	126154000000	-36853000000	442.32
common stock issued	0	0	NaN
common stock repurchased	-35000000	-50051000000	99.93
dividends paid	-57500000000	-53778000000	-6.92
net cash used provided by financing activities	35909000000	-167835000000	121.40
cash at end of period	131399000000	88060000000	49.22
accounts receivables	-13365000000	-8455000000	-58.07
cash at beginning of period	88060000000	149488000000	-41.09

Overall Score of Annual Cashflow Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 43,339 million in 2023 from -61,428 million in 2022 representing a change of 170.55%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 203,206 million in 2023 from 135,562 million in 2022 representing a change of 49.9%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 89,396 million in 2023 from 37,083 million in 2022 representing a change of 141.07%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -113,810 million in 2023 from -98,479 million in 2022 representing a change of -15.57%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 10,972 million in 2023 from 18,384 million in 2022 representing a change of -40.32%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -13,365 million in 2023 from -8,455 million in 2022 representing a change of -58.07%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Dividends Paid: Dividends Paid decreased to -57,500 million in 2023 from -53,778 million in 2022 representing a change of -6.92%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	68828000000	39883000000	72.57
free cash flow	22362000000	17884000000	25.04
capital expenditure	-46466000000	-21999000000	-111.22
depreciation and amortization	22227000000	21370000000	4.01
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-25531000000	49753000000	-151.32
accounts payables	10139000000	-10692000000	194.83
inventory	-9705000000	-14531000000	33.21
acquisitions net	-3134000000	-41732000000	92.49
investments in property plant and equipment	-46466000000	-21999000000	-111.22
net cash used for investing activites	-50680000000	-65345000000	22.44
debt repayment	-30788000000	91444000000	-133.67
common stock issued	0	0	NaN
common stock repurchased	-19651000000	-7418000000	-164.91
dividends paid	0	-29560000000	100.00
net cash used provided by financing activities	-56316000000	34748000000	-262.07
net change in cash	-12801000000	19808000000	-164.63
cash at end of period	138406000000	151207000000	-8.47
cash at beginning of period	151207000000	131399000000	15.07

Overall Score of Quarterly Cashflow Statement

0.86 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -12,801 million in 2024Q2 from 19,808 million in 2024Q1 representing a change of -164.63%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 68,828 million in 2024Q2 from 39,883 million in 2024Q1 representing a change of 72.57%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 22,362 million in 2024Q2 from 17,884 million in 2024Q1 representing a change of 25.04%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -46,466 million in 2024Q2 from -21,999 million in 2024Q1 representing a change of -111.22%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 10,139 million in 2024Q2 from 10,692 million in 2024Q1 representing a change of 194.83%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -25,531 million in 2024Q2 from 49,753 million in 2024Q1 representing a change of -151.32%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to 0 million in 2024Q2 from -29,560 million in 2024Q1 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	2635.53	2421.0	8.86
net income per share	139.16	135.09	3.01
operating cash flow per share	250.92	164.97	52.10
free cash flow per share	110.39	45.13	144.61
cash per share	173.29	117.35	47.67
book value per share	1760.61	1525.03	15.45
tangible book value per share	903.53	928.23	-2.66
shareholders equity per share	1398.5	1192.6	17.27
interest debt per share	913.33	644.47	41.72
market cap	1673156298000	1652549305000	1.25
enterprise value	2274837298000	2087610305000	8.97
pe ratio	14.85	14.89	-0.27
price to sales ratio	0.78	0.83	-5.63
pocfratio	8.23	12.19	-32.46
pfcf ratio	18.72	44.56	-58.00
pb ratio	1.48	1.69	-12.39
ptb ratio	1.48	1.69	-12.39
ev to sales	1.07	1.05	1.57
enterprise value over ebitda	7.72	8.02	-3.76
ev to operating cash flow	11.19	15.4	-27.31
ev to free cash flow	25.45	56.3	-54.80
earnings yield	0.07	0.07	0.27
free cash flow yield	0.05	0.02	138.10
debt to equity	0.65	0.53	21.26
debt to assets	0.26	0.21	24.15
net debt to ebitda	2.04	1.67	22.14
current ratio	1.42	1.4	1.54
interest coverage	30.58	17.91	70.77
income quality	1.8	0.71	154.56
dividend yield	0.03	0.03	5.60
payout ratio	0.51	0.48	5.32
sales general and administrative to revenue	0.36	0.36	-0.60
research and ddevelopement to revenue	0.04	0.04	-2.42
intangibles to total assets	0.24	0.19	25.39
capex to operating cash flow	0.56	0.73	-22.90
capex to revenue	0.05	0.05	7.72
capex to depreciation	1.3	1.15	13.86
stock based compensation to revenue	0	0	NaN
graham number	2092.55	1903.89	9.91
roic	0.07	0.04	53.98
return on tangible assets	0.05	0.05	-4.25
graham net net	-993.03	-901.32	-10.18
working capital	285015000000	254326000000	12.07
tangible asset value	731730000000	762777000000	-4.07
net current asset value	-485926000000	-402039000000	-20.87
invested capital	1572051000000	1305394000000	20.43
average receivables	427054000000	398544500000	7.15
average payables	201224000000	247368500000	-18.65
average inventory	310577500000	268700000000	15.59
days sales outstanding	76.09	75.07	1.36
days payables outstanding	41.28	89.31	-53.78
days of inventory on hand	99.55	97.73	1.86
receivables turnover	4.8	4.86	-1.34
payables turnover	8.84	4.09	116.34
inventory turnover	3.67	3.73	-1.83
roe	0.1	0.11	-12.15
capex per share	140.53	119.84	17.27

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 14.85 on 2023-12-31 from 14.89 on 2022-12-31, representing a change of -0.27%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.42 on 2023-12-31 from 1.40 on 2022-12-31, representing a change of 1.54%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.65 on 2023-12-31 from 0.53 on 2022-12-31, representing a change of 21.26%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
2503.T
calendar year	2024	2024	NaN
revenue per share	733.49	619.56	18.39
net income per share	38.67	31.98	20.92
operating cash flow per share	84.98	49.25	72.57
free cash flow per share	27.61	22.08	25.03
cash per share	170.89	197.74	-13.58
book value per share	1961.09	1799.62	8.97
tangible book value per share	925.23	813.85	13.69
shareholders equity per share	1593.31	1435.48	11.00
interest debt per share	900.48	938.18	-4.02
market cap	1693108493000	1703161413252	-0.59
enterprise value	2281975493000	2309423413252	-1.19
pe ratio	13.51	16.44	-17.79
price to sales ratio	2.85	3.39	-16.04
pocfratio	24.6	42.7	-42.40
pfcf ratio	75.71	95.23	-20.50
pb ratio	1.31	1.47	-10.44
ptb ratio	1.31	1.47	-10.44
ev to sales	3.84	4.6	-16.54
enterprise value over ebitda	25.75	39.23	-34.37
ev to operating cash flow	33.15	57.9	-42.74
ev to free cash flow	102.05	129.13	-20.98
earnings yield	0.02	0.02	21.64
free cash flow yield	0.01	0.01	25.78
debt to equity	0.56	0.65	-13.50
debt to assets	0.23	0.25	-7.97
net debt to ebitda	6.64	10.3	-35.48
current ratio	1.42	1.41	0.58
interest coverage	29.54	14.12	109.23
income quality	2.2	1.54	42.71
dividend yield	0	0.02	-100.00
payout ratio	0	1.14	-100.00
sales general and administrative to revenue	0.36	0.39	-8.10
research and ddevelopement to revenue	0.0	0.05	-99.68
intangibles to total assets	0.27	0.27	0.72
capex to operating cash flow	0.68	0.55	22.39
capex to revenue	0.08	0.04	78.40
capex to depreciation	2.09	1.03	103.07
stock based compensation to revenue	0	0	NaN
graham number	1177.43	1016.32	15.85
roic	0.02	0.01	68.30
return on tangible assets	0.01	0.01	16.21
graham net net	-1099.62	-1120.76	1.89
working capital	300235000000	284506000000	5.53
tangible asset value	749346000000	659114000000	13.69
net current asset value	-528927000000	-569335000000	7.10
invested capital	1774245000000	1689615000000	5.01
average receivables	421724500000	424378500000	-0.63
average payables	326328500000	313630000000	4.05
average inventory	364450500000	342050000000	6.55
days sales outstanding	66.6	72.43	-8.05
days payables outstanding	93.07	105.68	-11.94
days of inventory on hand	105.32	116.41	-9.53
receivables turnover	1.35	1.24	8.75
payables turnover	0.97	0.85	13.56
inventory turnover	0.85	0.77	10.53
roe	0.02	0.02	8.94
capex per share	57.37	27.16	111.21

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-06-30 Q2 from 0.02 on 2024-03-31 Q1, representing a change of 8.94%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 13.51 on 2024-06-30 Q2 from 16.44 on 2024-03-31 Q1, representing a change of -17.79%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.42 on 2024-06-30 Q2 from 1.41 on 2024-03-31 Q1, representing a change of 0.58%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.56 on 2024-06-30 Q2 from 0.65 on 2024-03-31 Q1, representing a change of -13.50%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 3628.68 which is higher than current price 1915, indicates the company may be undervalued.